We identified recurrent highly pathogenic variants affecting important drivers of hematological cancer (ATM [57]), epigenetic regulators (ISX [58] and SETDB1 [59]), and mediators of DNA replication (POLQ [60]). Here, ISX is linked to hematopoietic and lymphoid cell neoplasm.